Published: Jan. 1, 2024
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Language: Английский
Published: Jan. 1, 2024
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Language: Английский
Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: Feb. 21, 2025
Antibody-drug conjugates have emerged as a promising cancer treatment, combining targeted delivery of cytotoxic agents with the specificity monoclonal antibodies. Despite their potential, ADCs face limitations such resistance and off-target effects. To enhance efficacy, are increasingly being combined other therapeutic strategies, including immune checkpoint inhibitors, chemotherapy, small-molecule anti-angiogenic agents, CAR-T cell therapies. These combination therapies aim to overcome mechanisms, improve tumor targeting, boost responses. Clinical studies shown that combinations can significantly response rates progression-free survival across various cancers. This review explores clinical key studies, challenges, future perspectives in therapy.
Language: Английский
Citations
0Nanomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 19
Published: March 10, 2025
Cancer remains a significant global health challenge, driving the search for innovative treatments. Photothermal therapy (PTT) has emerged as promising approach, using photothermal agents to convert near-infrared (NIR) light into heat tumor ablation. Among these agents, nano-molybdenum oxide, particularly non-stoichiometric MoO3-x (0 < x 1), stands out due its unique defect structure, strong NIR absorption, high conversion efficiency (PCE), and pH-responsive degradation. This review summarized recent advancements in oxide PTT, covering classification, synthesis, surface modification, tumor-targeting mechanisms. Subsequently, we explored applications PTT combination therapies, evaluated biocompatibility toxicity, discussed current achievements, challenges, future perspectives cancer treatment.
Language: Английский
Citations
0ACS Applied Nano Materials, Journal Year: 2025, Volume and Issue: unknown
Published: March 28, 2025
Language: Английский
Citations
0Journal of Materials Chemistry B, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
An iron-metallized hollow COF nanobowl (FeHHCA) was synthesized for cancer sonodynamic therapy.
Language: Английский
Citations
0International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 653, P. 123898 - 123898
Published: Feb. 11, 2024
Language: Английский
Citations
3International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 269, P. 132074 - 132074
Published: May 3, 2024
Language: Английский
Citations
3Carbohydrate Polymers, Journal Year: 2024, Volume and Issue: 345, P. 122569 - 122569
Published: Aug. 2, 2024
Language: Английский
Citations
3European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 279, P. 116928 - 116928
Published: Sept. 30, 2024
Language: Английский
Citations
3International Journal of Pharmaceutics, Journal Year: 2023, Volume and Issue: 646, P. 123459 - 123459
Published: Sept. 29, 2023
Language: Английский
Citations
8International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 282, P. 137129 - 137129
Published: Oct. 31, 2024
Language: Английский
Citations
2